Spruce Biosciences Prices IPO Of 6.0 Mln Shares At $15, The Mid Of Expected Range

By RTTNews Staff Writer   ✉   | Published:

Spruce Biosciences, Inc. announced the pricing of initial public offering of 6.0 million common shares at $15.00 per share, the mid of the expected range of between $14.00 and $16.00 per share.

The company shares to begin trading on the Nasdaq Global Select Market on October 9, under the symbol "SPRB" and the offering is expected to close on October 14, 2020.

Spruce also granted the underwriters a 30-day option to buy additional 900,000 common shares at the public offering price less underwriting discounts and commissions.

Cowen, SVB Leerink, Credit Suisse and RBC Capital Markets are acting as joint book-running managers for the offering.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walt Disney Co. is reorganizing its media and entertainment businesses aiming to accelerate its direct-to-consumer or DTC strategy following the significant success of its streaming service Disney+. In a statement, the company stated that its media and entertainment businesses will be separated into creative engines, as well as Media and Entertainment Distribution Group. Johnson & Johnson (JNJ) has paused the phase III study of its COVID-19 vaccine candidate, JNJ-78436735, due to an unexplained illness in a study participant, Stat News reported, citing a document sent to outside researchers running the 60,000-patient clinical trial. Twitter has taken additional steps to prevent any manipulation or interference in the upcoming U.S. Elections or other civic processes through misleading Tweets. It announced significant product and enforcement updates to enable the smooth conduct of the democratic process. The social media platform has recently expanded its civic integrity policy to address misleading information.